503B Compounding Pharmacy

This month's column addresses compounding promethazine gel.

David G. Miller, RPh, discusses H.R. 3204, the Drug Quality and Security Act, which passed the House of Representatives on September 25, 2013.

David G. Miller, RPh, discusses the roles of the FDA and state boards of pharmacy in regulating compounding pharmacies.

The Drug Quality and Security Act, designed to improve the safety of compounded medications and to keep counterfeit and stolen medications out of the nation's drug supply, appears headed for passage by Congress.

Leaders from the Senate and House committees overseeing health policy announced that they have reached an agreement on legislation to help ensure the safety of compounded drugs and our nation's pharmaceutical supply chain.

This fall brings the final season of the series "Breaking Bad," and a recipe for a mouth-watering-and perfectly legal-form of crystal.

Although many pharmacies practice compounding, few pharmacy schools teach this skill to students. Should all pharmacy students learn specialized skills?

These pharmacists have specialized knowledge about pharmaceuticals and their use in treating cancer and its comorbidities, and they work collaboratively with the health care team to optimize outcomes.

Diplomat Specialty Pharmacy, the country's largest independent specialty pharmacy servicing the needs of patients and physicians nationwide, is pleased to announce the company's compounding pharmacy has been accredited by the Pharmacy Compounding Accreditation Board (PCAB).

The FDA indicated in a letter to SPAARx that future compounding legislation will omit the term "specialty pharmacy."

Urges continued distinction between prescription compounding and manufacturing

This important document outlines the responsibilities of the extemporaneous compounder.

The Specialty Pharmacy Association of America (SPAARx), the largest national association representing the broad interests of the specialty pharmacy industry, announced that it is launching a national advocacy initiative related to compounding that will be focused on pending federal and state legislation and regulation through agencies such as the FDA.

Some pharmacy operations will continue to need to outsource product compounding, but it is important that they take steps to do so safely.

Quantity of product and the training of the pharmacy professional are factors to consider in this question.

New legislation would allow the FDA to track the volume and distribution of drugs produced at compounding pharmacies, increase the transparency of compounded drugs, and institute a waiver system in times of public need.